InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,501.73
(
0.49%
)
US TECH 100
19,446.60
(
0.88%
)
Dow Jones
39,306.58
(
0.35%
)
Brent Oil
86.24
(
-0.34%
)
Bitcoin
61,888.30
(
-1.54%
)
Post# of 252462
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

mcbio

Send PM Follow Ignore
Followers 69
Posts 6152
Boards Moderated 0
Alias Born 11/26/2008

mcbio

Re: pcrutch post# 127722

Monday, 10/03/2011 10:10:51 PM

Monday, October 03, 2011 10:10:51 PM

Post# of 252462

Competition from ALNY: ALN-RSV01 interim analysis by ye2011 and study data 2012. Program is partnered with CBST. not too sure about market potential or data; only briefly glanced.

The existing clinical data for ALN-RSV01 hasn't been too impressive I don't believe so I don't know how concerned I am about this potential threat. (I do still find ALNY interesting for the rest of their pipeline and the valuation so I keep an eye on them.)
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up